Recently, the ability of SAIT301 to inhibit HGF-induced invasion and migration of nasopharingeal cancer cell lines has been described, suggesting a potential use for MET inhibitors in the treatment of this highly invasive and metastatic type of cancer [101]. The gene discussed is HGF; the disease is cancer.